Immunis Biomedical
Irvine, US · 4 known investors
Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases. Its approach targets multiple biological pathways at once rather than a single protein or mechanism.
BiotechHealthtechLongevity
Founders & leadership
HK
Hans KeirsteadChairman of the Board
Investors · 4
Frequently asked questions
- What does Immunis Biomedical do?
- Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases. Its approach targets multiple biological pathways at once rather than a single protein or mechanism.
- Who are Immunis Biomedical's investors?
- Immunis Biomedical's investors include Bold Capital Partners, JLS, quadraScope Venture Fund, Remiges Ventures, Inc..
- Where is Immunis Biomedical headquartered?
- Immunis Biomedical is headquartered in Irvine, US.